Synthesis, radiolabeling and animal studies of [^(131)I]MPPI: A 5-HTB_(1A) imaging agent  

Synthesis, radiolabeling and animal studies of [^(131)I]MPPI: A 5-HTB_(1A) imaging agent

在线阅读下载全文

作  者:SUN Bai-Shan LU Chun-Xiong ZOU Mei-Fen JIANG Quan-Fu WANG Song-Pei LI Xiao-Min CHEN Zheng-Ping ZHU Jun-Qing WU Chun-Ying 

机构地区:[1]Jiangsu Institute of Nuclear Medicine, Wuxi 214063, China [2]School of Biotechnology, The Key Laboratory of Biotechnology, Ministry of Education, Southern Yangtze University, Wuxi 214036, China

出  处:《Nuclear Science and Techniques》2006年第1期43-47,共5页核技术(英文)

基  金:Supported by grants from National Natural Science Foundation of China (30470496);"135" Medicinal Momentous Project of Jiangsu Province (RC2002068);Jiangsu Natural Science Foundation (BK2004423);Department of Personnel, Jiangsu Province (2003-07).

摘  要:The synthesis and biological evaluation of serotonin (5-HTB1AB) imaging agent [P131PI]- 4-iodo-N-{2-[4-(2-methoxyphenyl)-piperazin-1-yl]-ethyl}-N-pridin-2-yl-benzamide ([P131PI]MPPI ) are reported. The chemical structure of aimed compound and intermediates were confirmed by IR, P1PHNMR, and MS. Radiochemical purity was above 99% determined by TLC. Biodistribution of [P131PI]MPPI in rats displayed high uptake in hippocam-pus and low uptake in cerebellum. The ratio of the uptake of [P131PI]MPPI in hippocampus to that in cerebellum was 2.90 at 30 min post injection. The radioactivity in thyroid was 0.069 and 0.128% ID/g organ at 5 min and 120 min, respectively, and it was increased with time, which suggests that in vivo deiodination may be the major route of me-tabolism. Ex vivo autoradiography of brain section displayed significant decrease of radioactivity in hippocampus when pretreated with 8-OH-DPAT, a selective 5HTB1AB agonist, compared with control. These findings strongly sug-gested that P131PI-MPPI could be used as an in vivo marker for studies of pharmacology of the 5-HTB1AB receptor system in animals.The synthesis and biological evaluation of serotonin (5-HT1A) imaging agent [^131I]- 4-iodo-N-{2-[4-(2-methoxyphenyl)-piperazin-l-yl]-ethyl}-N-pridin-2-yl-benzamide ([^131I]MPPI) are reported. The chemical structure of aimed compound and intermediates were confirmed by IR, ^1HNMR, and MS. Radiochemical purity was above 99% determined by TLC. Biodistribution of [^131I]MPPI in rats displayed high uptake in hippocampus and low uptake in cerebellum. The ratio of the uptake of [^131I]MPPI in hippocampus to that in cerebellum was 2.90 at 30 rain post injection. The radioactivity in thyroid was 0.069 and 0.128% ID/g organ at 5 min and 120 rain, respectively, and it was increased with time, which suggests that in vivo deiodination may be the major route of metabolism. Ex vivo autoradiography of brain section displayed significant decrease of radioactivity in hippocampus when pretreated with 8-OH-DPAT, a selective 5HT1A agonist, compared with control. These findings strongly suggested that ^131I-MPPI could be used as an in vivo marker for studies of pharmacology of the 5-HT1A receptor system in animals.

关 键 词:动物研究 放射性同位素元素示踪 成像 生物评估 

分 类 号:R817[医药卫生—影像医学与核医学] TL8[医药卫生—放射医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象